{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:08:51Z","timestamp":1792537731054,"version":"4.5.0"},"reference-count":65,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although thrombosis frequently occurs in infectious diseases, the coagulopathy associated with COVID-19 has unique characteristics. Compared with bacterial sepsis, COVID-19-associated coagulopathy presents with minimal changes in platelet counts, normal prothrombin times, and increased D-dimer and fibrinogen levels. These differences can be explained by the distinct pathophysiology of the thromboinflammatory responses. In sepsis-induced coagulopathy, leukocytes are primarily responsible for the coagulopathy by expressing tissue factor, releasing neutrophil extracellular traps, multiple procoagulant substances, and systemic endothelial injury that is often associated with vasoplegia and shock. In COVID-19-associated coagulopathy, platelet activation is a major driver of inflammation\/thrombogenesis and von Willebrand factor and platelet factor 4 are deeply involved in the pathogenesis. Although the initial responses are localized to the lung, they can spread systemically if the disease is severe. Since the platelets play major roles, arterial thrombosis is not uncommon in COVID-19. Despite platelet activation, platelet count is usually normal at presentation, but sensitive biomarkers including von Willebrand factor activity, soluble P-selectin, and soluble C-type lectin-like receptor-2 are elevated, and they increase as the disease progresses. Although the role of antiplatelet therapy is still unproven, current studies are ongoing to determine its potential effects.<\/jats:p>","DOI":"10.1055\/s-0042-1749441","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T23:01:38Z","timestamp":1656025298000},"page":"055-061","source":"Crossref","is-referenced-by-count":34,"title":["Platelet Activation and Thrombosis in COVID-19"],"prefix":"10.1055","volume":"49","author":[{"given":"Toshiaki","family":"Iba","sequence":"additional","affiliation":[{"name":"Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Mie Prefectural General Medical Center, Mie, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijcard.2020.08.103","article-title":"Unusual arterial thrombotic events in COVID-19 patients","volume":"323","author":"C de Roquetaillade","year":"2021","journal-title":"Int J Cardiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"700292","DOI":"10.3389\/fcvm.2021.700292","article-title":"Thrombus of the aorta and SARS-CoV-2 infection: cause or trigger?","volume":"8","author":"G Goudot","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"07","key":"ref3","first-page":"e16171","article-title":"Aortic thrombosis and acute limb ischemia secondary to COVID hypercoagulability","volume":"13","author":"NB Burley","year":"2021","journal-title":"Cureus"},{"issue":"07","key":"ref4","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00134-020-06079-2","article-title":"Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19","volume":"46","author":"E Azouz","year":"2020","journal-title":"Intensive Care Med"},{"issue":"08","key":"ref5","doi-asserted-by":"crossref","first-page":"e244396","DOI":"10.1136\/bcr-2021-244396","article-title":"COVID-19-associated ischaemic stroke due to underlying carotid artery thrombosis in a healthy young woman","volume":"14","author":"K Lau","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/bjh.17986","article-title":"Unusual pattern of thrombotic events in young adult non-critically ill patients with COVID-19 may result from an undiagnosed inherited and acquired form of thrombophilia","volume":"196","author":"MI Elbadry","year":"2022","journal-title":"Br J Haematol"},{"issue":"09","key":"ref7","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/jth.14975","article-title":"Coagulopathy in COVID-19","volume":"18","author":"T Iba","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1055\/s-0040-1715456","article-title":"COVID-19 and venous thromboembolism: a meta-analysis of literature studies","volume":"46","author":"A Di Minno","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1365-2796.2011.02473.x","article-title":"Acute infections and venous thromboembolism","volume":"271","author":"M Schmidt","year":"2012","journal-title":"J Intern Med"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/hematology.2021000297","article-title":"How to recognize and manage COVID-19-associated coagulopathy","volume":"2021","author":"GF Gerber","year":"2021","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12185-020-03053-y","article-title":"Recent advances in the research and management of sepsis-associated DIC","volume":"113","author":"T Iba","year":"2021","journal-title":"Int J Hematol"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy","volume":"142","author":"L Nicolai","year":"2020","journal-title":"Circulation"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2021.08.012","article-title":"The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia","volume":"32","author":"T Iba","year":"2022","journal-title":"Trends Cardiovasc Med"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11239-020-02172-x","article-title":"Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19","volume":"50","author":"M Bautista-Vargas","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"08","key":"ref15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/17476348.2021.1899815","article-title":"Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy","volume":"15","author":"T Iba","year":"2021","journal-title":"Expert Rev Respir Med"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"ED Hottz","year":"2020","journal-title":"Blood"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3390\/biom11111550","article-title":"Mechanisms of immunothrombosis by SARS-CoV-2","volume":"11","author":"MT Hern\u00e1ndez-Huerta","year":"2021","journal-title":"Biomolecules"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"S Zhang","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"16","key":"ref19","doi-asserted-by":"crossref","first-page":"7448","DOI":"10.7150\/thno.48076","article-title":"SARS-CoV-2 pandemic and research gaps: understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy","volume":"10","author":"PK Datta","year":"2020","journal-title":"Theranostics"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/HYPERTENSIONAHA.120.15353","article-title":"COVID-19: ACE2centric infective disease?","volume":"76","author":"P Verdecchia","year":"2020","journal-title":"Hypertension"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1111\/jth.15534","article-title":"Platelets contribute to disease severity in COVID-19","volume":"19","author":"TJ Barrett","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref22","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3324\/haematol.2021.279000","article-title":"Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia","volume":"106","author":"K Althaus","year":"2021","journal-title":"Haematologica"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12964-020-00687-7","article-title":"Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19","volume":"18","author":"GA Arga\u00f1araz","year":"2020","journal-title":"Cell Commun Signal"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(21)00896-5","article-title":"Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study","volume":"398","author":"I Katsoularis","year":"2021","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"FA Klok","year":"2020","journal-title":"Thromb Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.avsg.2020.08.087","article-title":"Arterial thrombosis in coronavirus disease 2019 patients: a rapid systematic review","volume":"70","author":"I Cheruiyot","year":"2021","journal-title":"Ann Vasc Surg"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12959-021-00357-9","article-title":"Incidence and characteristics of arterial thromboemboli in patients with COVID-19","volume":"19","author":"N Glober","year":"2021","journal-title":"Thromb J"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1161\/STROKEAHA.120.031217","article-title":"Ischemic stroke occurs less frequently in patients with COVID-19: a multicenter cross-sectional study","volume":"51","author":"K Bekelis","year":"2020","journal-title":"Stroke"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis","volume":"506","author":"G Lippi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"F Zhou","year":"2020","journal-title":"Lancet"},{"issue":"03","key":"ref31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/09537104.2013.793794","article-title":"Mean platelet volume reproducibility and association with platelet activity and anti-platelet therapy","volume":"25","author":"B Shah","year":"2014","journal-title":"Platelets"},{"issue":"04","key":"ref32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0041-1727283","article-title":"Mean platelet volume predicts severe COVID-19 illness","volume":"47","author":"G Lippi","year":"2021","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02981974","article-title":"Functional property of von Willebrand factor under flowing blood","volume":"75","author":"M Sugimoto","year":"2002","journal-title":"Int J Hematol"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jth.15191","article-title":"The ADAMTS13-von Willebrand factor axis in COVID-19 patients","volume":"19","author":"I Mancini","year":"2021","journal-title":"J Thromb Haemost"},{"key":"ref35","first-page":"1","article-title":"High levels of Von Willebrand factor markers in COVID-19: a systematic review and meta-analysis","volume":"6","author":"M Rostami","year":"2021","journal-title":"Clin Exp Med"},{"issue":"04","key":"ref36","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0041-1727282","article-title":"Increased VWF and decreased ADAMTS-13 in COVID-19: creating a milieu for (micro)thrombosis","volume":"47","author":"EJ Favaloro","year":"2021","journal-title":"Semin Thromb Hemost"},{"issue":"08","key":"ref37","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/jth.15409","article-title":"ADAMTS13 regulation of VWF multimer distribution in severe COVID-19","volume":"19","author":"SE Ward","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"24","key":"ref38","doi-asserted-by":"crossref","first-page":"13638","DOI":"10.3390\/ijms222413638","article-title":"Prothrombotic phenotype in COVID-19: focus on platelets","volume":"22","author":"C Barale","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jclinpath-2020-206933","article-title":"Platelet aggregates, a marker of severe COVID-19 disease","volume":"74","author":"A Rampotas","year":"2021","journal-title":"J Clin Pathol"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"EA Middleton","year":"2020","journal-title":"Blood"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/CCM.0000000000005211","article-title":"Recognizing vaccine-induced immune thrombotic thrombocytopenia","volume":"50","author":"T Iba","year":"2022","journal-title":"Crit Care Med"},{"issue":"02","key":"ref42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11239-021-02583-4","article-title":"Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy","volume":"53","author":"R Cacciola","year":"2022","journal-title":"J Thromb Thrombolysis"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00392-004-0146-5","article-title":"P-selectin in arterial thrombosis","volume":"93","author":"M Merten","year":"2004","journal-title":"Z Kardiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cca.2008.09.018","article-title":"Soluble P-selectin as a marker of in vivo platelet activation","volume":"399","author":"P Ferroni","year":"2009","journal-title":"Clin Chim Acta"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"119634","DOI":"10.1016\/j.lfs.2021.119634","article-title":"Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: a case-control study","volume":"277","author":"E Karsli","year":"2021","journal-title":"Life Sci"},{"issue":"02","key":"ref46","doi-asserted-by":"crossref","first-page":"e3001109","DOI":"10.1371\/journal.pbio.3001109","article-title":"COVID-19 induces a hyperactive phenotype in circulating platelets","volume":"19","author":"SP Comer","year":"2021","journal-title":"PLoS Biol"},{"issue":"02","key":"ref47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-0037-1604090","article-title":"Platelet CLEC-2: roles beyond hemostasis","volume":"44","author":"K Suzuki-Inoue","year":"2018","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI122955","article-title":"Functional significance of the platelet immune receptors GPVI and CLEC-2","volume":"129","author":"J Rayes","year":"2019","journal-title":"J Clin Invest"},{"issue":"02","key":"ref49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/jth.13590","article-title":"Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood","volume":"15","author":"K Suzuki-Inoue","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2005-05-1994","article-title":"A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2","volume":"107","author":"K Suzuki-Inoue","year":"2006","journal-title":"Blood"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2019.03.018","article-title":"Elevated plasma levels of soluble C-type lectin-like receptor 2 (CLEC2) in patients with thrombotic microangiopathy","volume":"178","author":"Y Yamashita","year":"2019","journal-title":"Thromb Res"},{"issue":"13","key":"ref52","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.3390\/jcm10132860","article-title":"Soluble C-type lectin-like receptor 2 is a biomarker for disseminated intravascular coagulation","volume":"10","author":"A Yamamoto","year":"2021","journal-title":"J Clin Med"},{"issue":"03","key":"ref53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12185-019-02680-4","article-title":"Soluble CLEC-2 is generated independently of ADAM10 and is increased in plasma in acute coronary syndrome: comparison with soluble GPVI","volume":"110","author":"O Inoue","year":"2019","journal-title":"Int J Hematol"},{"issue":"15","key":"ref54","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.3390\/jcm10153408","article-title":"Soluble C-type lectin-like receptor 2 elevation in patients with acute cerebral infarction","volume":"10","author":"A Nishigaki","year":"2021","journal-title":"J Clin Med"},{"issue":"04","key":"ref55","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3390\/jcm11040985","article-title":"Plasma soluble C-type lectin-like receptor 2 is associated with the risk of coronavirus disease 2019","volume":"11","author":"H Wada","year":"2022","journal-title":"J Clin Med"},{"issue":"02","key":"ref56","doi-asserted-by":"crossref","first-page":"e000741","DOI":"10.1136\/fmch-2020-000741","article-title":"Rationales and uncertainties for aspirin use in COVID-19: a narrative review","volume":"9","author":"HA Sayed Ahmed","year":"2021","journal-title":"Fam Med Community Health"},{"issue":"04","key":"ref57","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1213\/ANE.0000000000005292","article-title":"Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with Coronavirus disease 2019","volume":"132","author":"JH Chow","year":"2021","journal-title":"Anesth Analg"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.amjcard.2020.12.073","article-title":"Meta-analysis of the effect of aspirin on mortality in COVID-19","volume":"142","author":"HM Salah","year":"2021","journal-title":"Am J Cardiol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ajem.2021.01.016","article-title":"Effect of antiplatelet treatments on patients with COVID-19 infection: a systematic review and meta-analysis","volume":"43","author":"Y Wang","year":"2021","journal-title":"Am J Emerg Med"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01825-0","article-title":"Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"399","author":"RECOVERY Collaborative Group","year":"2022","journal-title":"Lancet"},{"issue":"17","key":"ref61","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.2021.17272","article-title":"Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial","volume":"326","author":"JM Connors","year":"2021","journal-title":"JAMA"},{"issue":"02","key":"ref62","doi-asserted-by":"crossref","first-page":"e0246825","DOI":"10.1371\/journal.pone.0246825","article-title":"Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration","volume":"16","author":"TF Osborne","year":"2021","journal-title":"PLoS One"},{"issue":"04","key":"ref63","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ajh.26102","article-title":"Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis","volume":"96","author":"ML Meizlish","year":"2021","journal-title":"Am J Hematol"},{"issue":"07","key":"ref64","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00392-020-01783-x","article-title":"Impact of oral anticoagulation on clinical outcomes of COVID-19: a nationwide cohort study of hospitalized patients in Germany","volume":"110","author":"GM Fr\u00f6hlich","year":"2021","journal-title":"Clin Res Cardiol"},{"issue":"02","key":"ref65","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11239-021-02383-w","article-title":"Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients","volume":"52","author":"G Ho","year":"2021","journal-title":"J Thromb Thrombolysis"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1749441.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:35:45Z","timestamp":1672965345000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1749441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":65,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2023,1,5]]},"published-print":{"date-parts":[[2023,2]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1749441","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]}}}